Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,978 | 23,690 | 19,750 | 28,921 | 34,475 |
| Marketable Securities | 86,634 | 42,460 | 66,020 | 63,601 | 62,553 |
| Receivables | 13,835 | 624 | 0 | 6,582 | 4,335 |
| Inventories | 1,915 | 4,550 | 0 | 0 | 0 |
| Other current assets | 0 | 1,716 | 7,130 | 536 | -16,354 |
| TOTAL | $134,142 | $73,040 | $92,900 | $99,640 | $85,009 |
| Non-Current Assets | |||||
| PPE Net | 36,934 | 36,290 | 33,010 | 32,712 | 34,297 |
| Investments And Advances | 37,025 | 27,430 | 30,840 | 35,883 | 18,170 |
| Other Non-Current Assets | 173 | 210 | 150 | 145 | 100 |
| TOTAL | $74,132 | $63,930 | $64,000 | $68,740 | $52,567 |
| Total Assets | $208,274 | $136,990 | $156,910 | $168,380 | $137,581 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,446 | 6,550 | 5,550 | 4,663 | 2,170 |
| Accrued Expenses | N/A | N/A | 0 | 0 | 2,170 |
| Other current liabilities | N/A | 5,320 | 2,730 | 4,181 | 4,100 |
| TOTAL | $13,786 | $13,310 | $9,400 | $10,687 | $12,048 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,466 | 1,520 | 1,600 | 1,674 | 1,740 |
| Deferred Revenues | 3,728 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 294 | 280 | 280 | 242 | 180 |
| TOTAL | $12,358 | $14,130 | $16,260 | $18,794 | $18,590 |
| Total Liabilities | $26,144 | $27,460 | $25,680 | $29,481 | $30,650 |
| Shareholders' Equity | |||||
| Common Shares | 37 | 30 | 30 | 30 | 20 |
| Retained earnings | -223,518 | -200,300 | -177,230 | -168,607 | -157,020 |
| Other shareholders' equity | -780 | -490 | -140 | -632 | -809 |
| TOTAL | $182,130 | $109,530 | $131,220 | $138,899 | $106,931 |
| Total Liabilities And Equity | $208,274 | $136,990 | $156,900 | $168,380 | $137,581 |